Here at the Investing News Network our mission is twofold: to provide the latest news and quality education by helping you identify investment opportunities in niche markets, and helping leading companies communicate their value to investors.
Connecting investors with opportunities is what we do best. We are proud to present several companies which are new to the Investing News Network.
Below you will find links to educational profiles on leading companies offering opportunities in growth markets such as Gold, Lithium, Manganese, Cannabis, and Life Science.
Please note these profiles are not buy recommendations. There are many factors that you should consider before purchasing stocks. The purpose of these profiles is to present an in-depth value proposition for each company and provide you with the opportunity to easily request more information for your due diligence.
New to the Investing News Network, July 2017:
Silvercorp Metals (TSX:SVM, NYSEMKT:SVM) is one of the world’s lowest-cost, highest-margin primary silver producers. The Canadian mining company holds a portfolio of producing silver-lead-zinc mines in China, including the multi-mine Ying District in Henan Province and its newest mine the GC Mine in Guangdong Province.
Westhaven Ventures (TSXV:WHN) is putting the pieces together for what it hopes will be the next major gold district in British Columbia, based upon an exciting geological trend known as the Spences Bridge Gold Belt (SBGB). Westhaven Ventures is working on a plan to drill all three properties, with a view to assembling a collection of drill results that will identify the source of the Fraser River Gold Rush that could eventually become the next B.C. gold mine.
MYM Neutraceuticals (CSE:MYM) is an emerging cannabis grower and nutraceuticals manufacturing and distribution company focused on Canadian, United States and International medical marijuana markets. The company’s aggressive strategy for success is based on a commitment to superior growing technology, well-crafted branding and innovative distribution strategies.
Beleave (CNSX:BE) is a Canadian biotech company and an an authorized licensed producer of medical-grade cannabis under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The company’s larger strategy is to obtain cultivation and sales licenses and build out North American and European distribution channels. Beleave then hopes to expand production and capitalize on expected demand-growth spurred by cannabis legalization across Canada and in select US states.
Global Cannabis Applications (CSE:APP, FRA:2FA, OTCQB:FUAPF) is a leading developer of cutting-edge smartphone apps and has a global reach across more than 25 countries. Citizen Green, the company’s primary solutions, are medical cannabis-centric mobile platforms “dedicated to the digital world of all things medicinal cannabis”.
Friday Night Inc. (CSE:TGIF, FWB:1QF, OTC:VPGDF) is a Nevada-licensed cannabis producer building a lifestyle-focused brand to serve both the medical and recreational cannabis markets. Nevada is a medical marijuana state which voted to legalize recreational marijuana in 2016. The legislation has huge potential for the state’s largest city, Las Vegas—one of North America’s premiere tourist destinations. With over 45 million visitors every year, Las Vegas could easily become one of the world’s largest adult-use cannabis markets.
PUF Ventures (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF) is a late-stage applicant under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) with a goal of becoming a leading supplier of medical marijuana in Canada. The company is advancing through Stage 5 “Review” and awaiting notice from Health Canada for the Stage 6 Pre-Licensing Inspection. PUF holds majority ownership of a fully-constructed grow facility located in London, Ontario. The company will be granted full-ownership of the facility upon receipt of the ACMPR license.
New to the Investing News Network June 2017:
Broadway Gold Mining Ltd. (TSXV:BRD) specializes in defining and developing resource assets for potential merger and acquistions. Broadway Gold’s current focus is its 100 percent stake in the Madison copper-gold project, located in the famous Butte-Anaconda Mining region just 37 kilometers southeast of Butte, Montana.
Canuc Resources Corporation (TSXV:CDA) is engaged in developing value from its 100 percent owned and titled high quality, high grade San Javier Silver/Gold Project located in Sonora State, Mexico. After six years of claim acquisition and project preparation in a private company, the San Javier Silver/Gold asset has been brought to public markets for the first time through Canuc Resources Corporation.
Enforcer Gold Corp. (TSXV:VEIN) is a junior mining exploration company earning a 100-percent interest in the Montalembert Gold Project located in Quebec, Canada. The gold-bearing vein structures discovered on the property are classic shear-hosted quartz-carbonate gold mineralization, which is the most significant source of gold in the Abitibi greenstone belt.
Giyani (TSXV:WDG) has repositioned itself to become a “one-stop raw materials shop” for the emerging battery manufacturing sector. The Ontario, Canada-based company recently acquired a significant land package in Botswana and is on the verge of closing deals for two additional property acquisitions containing two past-producing manganese mines in Zambia – all of which it plans to explore and develop further.
Luminor Medical Technologies (TSXV:LMT) is a medical diagnostic company working to commercialize the world’s first non-invasive testing system designed to accurately screen for pre-diabetes and type 2 diabetes.
Neo Lithium Corp. (TSXV:NLC, OTCQX:NTTHF) is an emerging lithium brine exploration company in the world’s leading lithium production hub, South America’s Lithium Triangle. The company is aggressively advancing on its wholly-owned 3Q Project located in Catamarca Province, Argentina’s largest lithium producer. The newly discovered 3Q Project’s unique geochemistry makes it one of the highest-grade and lowest-impurity salars in the world.
Portofino Resources Inc. (TSXV:POR) is focused on lithium and gold projects in the Americas. The company’s main focus is its recently acquired lithium projects located within Argentina’s Catamarca Province, one of the leading lithium production centers in South America’s Lithium Triangle. Portofino Resources’ goals for 2017 include confirming the high grades for lithium and potassium interpreted from historical 2012 sampling data, and reviewing other potential acquisitions in the vicinity of its current properties. The company recently completed the first tranche of a private placement, with gross proceeds totaling $461,000 to fund project exploration.
Signature Resources Ltd. (TSXV:SGU, OTCQB:SGGTF) is an emerging gold exploration company with 100-percent control of the historic Lingman Lake property in the favorable mining jurisdiction of Ontario, Canada. The property hosts a high-grade brownfield gold deposit comprised of five major zones of gold mineralization and an historic estimate of 234,648 ounces grading 6.86 g/t gold*. Historic bulk samples demonstrated even higher grades, average 17.3 g/t gold.
WeedMD Inc. (TSXV:WMD) is leveraging its well-established relationships and experience in the long-term care and senior living industry to become the leading cannabis provider to this overlooked and valuable market segment. The company is a licensed producer under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) and will complete a listing as a Tier 1 life sciences issuer on the TSX Venture Exchange in April 2017.
Agreement propels development of safe and effective proprietary products and formulations for the emerging psychedelic industry
Optimi Health Corp. (CSE: OPTI) (“Optimi” or the “Company”), developers of a vertically integrated functional mushroom brand focused on the health and wellness sector, is pleased to announce that effective January 4, 2021, it entered into a lab services agreement with Numinus Wellness Inc. (“Numinus“). Recognized as an early leader in developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), Numinus is aiding Optimi’s mission to further the research and development of Canadian-grown psilocybin-producing mushrooms and related product formulations.
Nextleaf Solutions Provides a Corporate Update and Comments on Financial Results from the First Quarter
Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), the world’s most innovative cannabis processor, is pleased to provide shareholders with the following corporate update:
Nextleaf Comments on Financial Results from Q1 Financials
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”) reported its second quarter results for the period ended December 31, 2020. A complete set of financial statements and Management’s Discussion & Analysis has been filed at www.sedar.com. All dollar figures are quoted in Canadian dollars.
The second quarter of FY21, saw continued momentum for the Company despite ongoing pandemic related challenges. Net revenue grew 8% to $745,748 from $689,276 versus the same quarter year ago. The Company also saw significant improvement on its bottom line, reducing its net loss by 50% from ($.956) million to ($.481) million, year over year for the quarter, as a result of improved gross margin and cost management efforts. On December 9, 2020, the company announced the closing of the acquisition of substantially all of the assets of Lexaria Canpharm (“Canpharm“), the cannabis products division of Lexaria Biosciences, resulting in the addition of a new B2B Line of Business.
FinCanna Capital – The Only Publicly Traded, Royalty-Focused Company for the Licensed U.S. Cannabis Industry Provides Corporate Update
Royalty Model Provides Access to Early Stage Licenced U.S. Cannabis Companies and Leverage to High-Margin Revenues
FinCanna Capital Corp. (“FinCanna” or the “Company”) (CSE:CALI), a royalty company for the licensed U.S. cannabis industry, is pleased to provide a corporate update further to its recently announced upsized financing of $2 million
Significant progress made as Numinus-sponsored PRIME study on psilocybin-assisted psychotherapy for opioid, stimulant and/or alcohol use disorders enters pre-implementation stage
Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), and Syreon Corporation (Syreon), a global contract research organization with expertise in conducting clinical trials across a broad range of diseases, are pleased to share that significant progress has been made in the single-arm, open-label compassionate access 1 trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME) for substance use disorders. Currently in the development stage, the PRIME study will assess the efficacy and safety of psilocybin-assisted motivational enhancement therapy.